United Therapeutics (UTHR) Earnings Date, Estimates & Call Transcripts → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free uthr Stock Alerts $239.99 +5.52 (+2.35%) (As of 02:46 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 1EstimatedActual EPS (Feb. 21) $4.36 Beat By $0.08 Consensus EPS (Feb. 21) $4.28 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get United Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for UTHR and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueUTHR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.UTHR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 United Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242$5.10$5.93$5.52Q2 20243$5.55$6.32$5.86Q3 20243$5.60$7.04$6.11Q4 20242$5.04$6.67$5.86FY 202410$21.29$25.96$23.34Q1 20251$5.79$5.79$5.79Q2 20251$5.83$5.83$5.83Q3 20251$5.80$5.80$5.80Q4 20251$5.44$5.44$5.44FY 20254$22.86$22.86$22.86UTHR Earnings Date and InformationUnited Therapeutics last issued its quarterly earnings data on February 21st, 2024. The biotechnology company reported $4.36 EPS for the quarter, beating analysts' consensus estimates of $4.28 by $0.08. The firm earned $614.70 million during the quarter, compared to analyst estimates of $575.01 million. Its revenue for the quarter was up 25.1% compared to the same quarter last year. United Therapeutics has generated $19.84 earnings per share over the last year ($19.84 diluted earnings per share) and currently has a price-to-earnings ratio of 12.1. Earnings for United Therapeutics are expected to grow by 5.56% in the coming year, from $23.76 to $25.08 per share. United Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off prior year's report dates.Read More United Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/1/2024Estimated)------- 2/21/2024Q4 2023$4.28$4.36+$0.08$4.36$575.01 million$614.70 million 11/1/2023Q3 2023$5.10$5.38+$0.28$5.38$585.82 million$609.40 million 8/2/2023Q2 2023$4.57$5.24+$0.67$5.24$524.18 million$596.50 million 5/3/2023Q1 2023$4.26$4.86+$0.60$4.86$514.37 million$506.90 million 2/22/2023Q4 2022$4.12$2.67($1.45)$2.67$519.20 million$491.50 million 11/2/2022Q3 2022$3.57$4.91+$1.34$4.91$492.92 million$516.00 million Get the Latest News and Ratings for UTHR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for United Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/3/2022Q2 2022$4.10$2.41($1.69)$2.41$461.06 million$466.90 million 5/4/2022Q1 2022$2.96$5.03+$2.07$5.03$420.02 million$461.90 million 2/24/2022Q4 2021$3.77$2.35($1.42)$2.35$427.59 million$415.20 million 11/3/2021Q3 2021$3.37$3.42+$0.05$3.42$421.45 million$444.70 million 8/4/2021Q2 2021$3.02$3.65+$0.63$3.65$378.54 million$446.50 million 5/5/2021Q1 2021$2.60$0.61($1.99)$0.61$368.31 million$379.10 million United Therapeutics Earnings - Frequently Asked Questions When is United Therapeutics's earnings date? United Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off last year's report dates. Learn more on UTHR's earnings history. Did United Therapeutics beat their earnings estimates last quarter? In the previous quarter, United Therapeutics (NASDAQ:UTHR) reported $4.36 earnings per share (EPS) to beat the analysts' consensus estimate of $4.28 by $0.08. Learn more on analysts' earnings estimate vs. UTHR's actual earnings. How can I listen to United Therapeutics's earnings conference call? The conference call for United Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read United Therapeutics's conference call transcript? The conference call transcript for United Therapeutics's latest earnings report can be read online. Read Transcript How can I view United Therapeutics's earnings report? United Therapeutics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does United Therapeutics generate each year? United Therapeutics (NASDAQ:UTHR) has a recorded annual revenue of $2.33 billion. How much profit does United Therapeutics generate each year? United Therapeutics (NASDAQ:UTHR) has a recorded net income of $984.80 million. UTHR has generated $19.84 earnings per share over the last four quarters. What is United Therapeutics's price-to-earnings ratio? United Therapeutics (NASDAQ:UTHR) has a trailing price-to-earnings ratio of 12.10 and a forward price-to-earnings ratio of 10.10. What is United Therapeutics's EPS forecast for next year? United Therapeutics's earnings are expected to grow from $23.76 per share to $25.08 per share in the next year, which is a 5.56% increase. More Earnings Resources from MarketBeat Related Companies: IONS Earnings Results BMRN Earnings Results MDGL Earnings Results ALKS Earnings Results ALNY Earnings Results FOLD Earnings Results SRPT Earnings Results CTLT Earnings Results RDY Earnings Results KRTX Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:UTHR) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
